Simple Plex AAV2 assay combines the scalability and automation of Ella with best-in-class AAV reagents from PROGEN MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) and PROGEN today announced the launch of the Simple Plex™ Adeno-Associated Virus (AAV2) viral titer assay for AAV2 total capsid quantification.  Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of […]

Stockholm / Zürich — Atlas Antibodies has agreed to acquire evitria, a world leader in transient recombinant antibody expression in CHO cells. This transformative acquisition brings together a leading provider of highly validated research antibodies and a front-runner in the field of custom recombinant antibody expression. Since its inception in 2010, evitria has been singularly […]

ROCHESTER HILLS, Mich. — Oxford Biomedical Research, Inc., a privately held biotechnology company, has been awarded a $99,203 Phase I Small Business Innovation Research Grant by the National Institute of Food and Agriculture [NIFA, award #2021-33530-34397]. This grant, entitled “SIMPLE & RAPID TESTS FOR THE QUALITY OF ANIMAL FEEDS” will support the development of rapid tests to evaluate the […]

AMSBIO has launched a new range of research grade biosimilars that enable analysis of biological processes without the need to purchase expensive therapeutic-grade biologics. Investigating the biological effects of a drug or doing proof of concept assay development, requires a source of the drug. Typically, it is difficult to obtain original pharmaceutical grade biotherapeutic drugs for research use, […]

Transformative deal significantly scales leading position in life science to accelerate legendary discoveries in precision medicine Leader in antibody development with highly complementary, innovative portfolio in emerging, high-growth areas of biologics, cell and gene therapy, proteogenomics, and recombinant proteins Commercial synergy opportunity to accelerate life science growth with potential benefits for diagnostics franchise Annual BioLegend revenues of […]

iRiS Kinetics and axiVEND announced today an agreement to expand their partnership. axiVEND will now assemble iRiS Kinetics MX-100 systems and produce all of the iRiS Chips, all under GMP protocols. In addition, iRiS Kinetics has appointed Claude Dufresne as its Chief Commercialization Officer, with worldwide responsibilities for to market and distribute the product line. […]

Cardea Bio, a Tech+Bio company that has integrated molecular biology with semiconductor electronics, today announced that Dawn Barry has joined the company’s Board of Directors. Dawn Barry is the President & co-founder of LunaPBC, Inc., which was named by the World Economic Forum as a Technology Pioneer in 2019. SAN DIEGO — Cardea technology taps […]

Supports accelerated growth of R&D, manufacturing, and commercial activities with new 100,000 sq-ft state-of-the-art facility Reinforces commitment to the region as Abcam approaches 20 years of US presence Cambridge, UK: Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA. The new facility […]

UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) today announced that deCODE genetics, a global leader in analyzing and understanding the human genome, will have internal access to the Olink® Explore 3072 platform, comprised of approximately 3,000 high quality protein assays with a Next Generation Sequencing (NGS) read-out. Through an agreement between the two […]

NEW YORK & BOULDER, Colo. — CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a leader in proteomics technology, announced today that Beth Israel Deaconess Medical Center’s (BIDMC) Genomics, Proteomics, Bioinformatics, and Systems Biology Center in Boston, Mass. will be the first site to offer the 7,000-plex SomaScan® Assay kits in their core lab […]